Profile: ADVENTRX Pharmaceuticals, Inc. operates as a biopharmaceutical research and development company. The company focuses on new technologies for anticancer and antiviral treatments, which address drug metabolism, toxicity, bioavailability, or resistance problems.
Website: http://www.adventrx.com
ANX was already mentioned several times by Saffeysite1 (http://www.3stocksonfire.org/trading/index.php?topic=54.0) on the Stock Picking Board, but now it has attracted my attention...
Technical Overview:
ANX developed a symmetrical triangle formation on the last months, the breakout was made in mid-July, since then, the stock has been very technical, trading inside an Ascending Channel, having good volume on the up-moves, and decreasing it's volume on the deeps.
Right now, ANX just reacted on the base of this channel.
The target of the symmetrical triangle is $4.39, which I believe it could be reached on the short term with the right market conditions.
Trading Setup:
I'm buying ANX today near the open.
The Target for this trade is the price zone near $4.39.
The stop will be $3.19 (then, if the trade goes the right way, I'll move the stop to trailing stop along the base of the channel)
(This recommendation was made by Frederick Ramsburg from 3 Stocks on Fire. 3 Stocks on Fire is a Community of stock traders and investors. Our 2863 members change trading ideas and strategies on our message boards everyday. We welcome you as a new member of the 3 Stocks on Fire Community, please take 10 seconds to register (http://www.3stocksonfire.org/trading/index.php?action=register) and receive our free newsletter)
Best regards,
Bought ANX @ 3.47
Great pick for 3sof portfolio Ramsburg! (applaud) look at this one moving..wow! Volume surpassed yesterdays volume by 10am. woohoo 8) >:D
David,
Any updates on ANX?
For me, playing technical only is quite uncomfortable.
I need to know the fundamental before putting money into a stock.
For example, VPHM - based on its fundamental, the fiar value for the company is now around $20 within a year. Therefore I have some faith putting money on its pull back and I may double my position if it goes down further because I know the value is there.
What is the trading plan for ANX?
Hello,
Yesterday, I was out of town so I was unable to update this trade.
I can't say I'm enjoying this trade, ANX has broken the short term ascending support line, which by itself give a reason to drop this position.
Although, ANX is trying to reverse this short term move today, and I'll give it some room to see what's going on...
Best regards,
Ramsburg,
I think your uptrend channel is a little conservative. You won't be disappointed holding this one. This is just my opinion and I'm in @ 3.04.
This trade is not going exactly as planed...
ANX needs a fast breakout of the $3.60 price level in order to sustain its momentum, otherwise I'll be forced to sell this position.
I know ANX has a great mid-term technical pattern, but I'm playing short term here. So I'm keeping ANX once again, but I have my finger on the trigger.
Best regards,
Ramsburg - What's your definition of short term?
I'm in San Diego on a beach all next week, and wonder how much space you recommend giving this.
Best Regards,
KCS
Quote from: KCScott on August 17, 2005, 11:34:29 PM
Ramsburg - What's your definition of short term?
I'm in San Diego on a beach all next week, and wonder how much space you recommend giving this.
Best Regards,
KCS
Hi KCS,
For me short term, is no more then a few weeks. But in this specific case, I need an upside breakout to keep the ANX trading plan (which was a $4.39 short term target).
My stop on this trade (if I don't close it before that) is a close below $3.19.
Enjoy your days at the beach ! 8)
best regard,
Nice session on ANX, the stock is going on the right direction...
Yesterday I asked for a breakout of the $3.60 level... almost today... I'm looking forward for tomorrow...
No special update for ANX...
The stock is feeling a little resistance on these levels, but the overall pattern is pointing the north direction... All we need is a significant breakout of the $3.60 zone, and we should watch another good advance. Let's wait, and give some room to ANX...
Been in this little gem since 1.27*. If you want some actual research that has been done extensively on what it is Adventrx is doing then you might want to read the research posts, of which many have been done mainly by Woodnstream, Biotechman22, Kingpindaddy, Mathwiz and a few others.
I think that if you do even the slightest bit of DD on what this company has going for them and is in the process of doing while taking future possibilities into consideration these shares are still a Steal at these levels.
Imho of course
Buying on dips, still loong in ANX
Shy gypsy slyly spryly tryst by my crypt
ANX is working the bullish patterns on the right direction again... But it still needs some push for a consistent breakout.
Thanks for your input ickabodcrane52.
This stock is breaking out today! Big jump!
Ready to buy now?????????
http://stockcharts.com/def/servlet/SC.web?c=anx,uu[h,a]daclyyay[da][pb50!b200][vc60][iUb14!La12,26,9]&pref=G
Quote from: snowcat on August 23, 2005, 01:45:50 PM
This stock is breaking out today! Big jump!
Ready to buy now?????????
http://stockcharts.com/def/servlet/SC.web?c=anx,uu[h,a]daclyyay[da][pb50!b200][vc60][iUb14!La12,26,9]&pref=G
Hi Snowcat,
ANX was bought for the 3SOF Portfolio on August the 11th @ $3.47
http://www.3stocksonfire.org/trading/index.php?topic=2192.msg15470#msg15470
Trading Setup:
I'm buying ANX today near the open.
The Target for this trade is the price zone near $4.39.
The stop will be $3.19 (then, if the trade goes the right way, I'll move the stop to trailing stop along the base of the channel)
Quote
Frederick,
Do you still plan on using a trailing stop on this one? And if so, where will you place it?
Thanks, basanlas
Hi !
Finally, ANX gave us the required technical breakout.
Big volume today and a nice 8.22% price advance to new relative highs make me believe that we can watch the $4.39 target soon...
I've made some changes on the technical chart, I've just deleted the short term ascending channel, and I'm using the new adjusted ascending support ($3.54 right now), which will be my trailing stop level from now on (closing values).
The plan is to sell ANX @ $4.39, although, momentum may increase if volume stays high as today, so I'm not placing a sell order yet... ;)
Best regards,
Booyah Fred! (I believe that's how a certain crazed TV analyst would congratulate you :P)
I'm vactioning this week, but caught the spike on ANX this afternoon on my Mobile.
Just wanted to say "Well Done" on sticking with this.
Let's all hope for an extended ride.
Best Regards,
KCS
Strong finish will happen, at or near the 52 week hi !!!!!
STRONG UPTREND approaching the target !! ;D
Quote from: KCScott on August 24, 2005, 12:47:45 AM
Booyah Fred! (I believe that's how a certain crazed TV analyst would congratulate you :P)
I'm vactioning this week, but caught the spike on ANX this afternoon on my Mobile.
Just wanted to say "Well Done" on sticking with this.
Let's all hope for an extended ride.
Best Regards,
KCS
Thanks KCS ;)
Have a nice time on the beach ;)
And remember that you can also access 3SOF website on your mobile @
http://wap2.3stocksonfire.org
ANX is going the right way ;)
Just a little update on this trade:
ANX had a very volatile session on Friday, with a big morning deep, but with a nice recovery on the rest of the session.
ANX is working on the right way, and I believe this week we'll meet our target @ $4.39. Volume has rise again on this recent breakout and follow up sessions, taking on consideration the rest of the market have generally dropped a lot, this is a signal of relative strength, which is bullish on this particular stock.
Best regards,
We've observed another down session on ANX yesterday, but not compromising our plan neither the general up pattern on the chart.
The ascending support line is now spotted over the $3.73, so this will be our reference price for today.
Best regards,
Yesterday ANX reacted on the ascending support, which is bullish... ;)
regards,
ANX is obeying to its ascending support line, so we have no reasons to change the trading plan.
My short term target is $4.39, my trailing stop is around $3.80, lets wait... A breakout of the $4.20 price level will probably shot ANX to my target in a lapse of time ;)
Best regards,
Hi !
Yesterday, ANX closed a bit bellow its ascending support, decreasing the momentum of this move, and putting at risk the short term pattern that I'm trading right now.
The general mid-term pattern of ANX is still very bullish, but taking in consideration this is a short term play, I may have to sell ANX today if is crosses $3.80 (automatic stop) or if it doesn't close higher than $3.97.
Stay alert !
I've sold ANX @ $3.80 following my trading plan.
best regards,
ANX painted a doji star (reversal) after a strong finish today. Holding ...
The rebound of ANX looks very boolish to me.
The 13ema, 20ema, and the last month support ascending line are all actiing again as supports levels.!
I see 5.20$ as my first target and my second target would be 5.45$ with is the top of the ascending channel.
Here is an update chart from ANX after the 3 days sellof of the market.
Today shows how strong is the support ascending line, the stock test it and rebound, this is the 5th times ANX test the line!
About the news from today, It looks like ANX need more cash! Saying that, I am not sure how to read it exactly. Are we talking about dillution(like printing more shares) or is it just ANX intention's of selling a few shares(15,495,867) from they own reserve, which would allready be accounted in the last oustanding Shares figure?
Thanks to anybody who could gives me a answer!
SAN DIEGO, May 16, 2006 /PRNewswire-FirstCall via COMTEX/ -- ADVENTRX Pharmaceuticals, Inc. (ANX) today announced that it plans to publicly offer 15,495,867 shares of its common stock in a firm commitment underwritten offering pursuant to an effective registration statement previously filed with the Securities and Exchange Commission. In connection with this offering, ADVENTRX plans to grant to the underwriters a 30-day option to purchase up to an additional 2,324,380 shares of common stock to cover over-allotments, if any. All of the shares are being sold by ADVENTRX. UBS Investment Bank is the sole book-running manager in this offering. CIBC World Markets Corp. and RBC Capital Markets are acting as co-lead managers, and Fortis Securities LLC is acting as co-manager.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. Copies of the preliminary prospectus may be obtained from UBS Investment Bank, Prospectus Department, 299 Park Avenue, New York, NY 10171 or by phone at 212-821-3000.
About ADVENTRX
ADVENTRX Pharmaceuticals is a biopharmaceutical research and development company focused on introducing treatments for cancer and infectious diseases that surpass the performance and safety of existing drugs, by addressing significant problems such as drug metabolism, toxicity, bioavailability and resistance
SAN DIEGO, May 16, 2006 /PRNewswire-FirstCall via COMTEX/ -- ADVENTRX Pharmaceuticals, Inc. (ANX) today announced that it plans to publicly offer 15,495,867 shares of its common stock in a firm commitment underwritten offering pursuant to an effective registration statement previously filed with the Securities and Exchange Commission. In connection with this offering, ADVENTRX plans to grant to the underwriters a 30-day option to purchase up to an additional 2,324,380 shares of common stock to cover over-allotments, if any. All of the shares are being sold by ADVENTRX. UBS Investment Bank is the sole book-running manager in this offering. CIBC World Markets Corp. and RBC Capital Markets are acting as co-lead managers, and Fortis Securities LLC is acting as co-manager.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. Copies of the preliminary prospectus may be obtained from UBS Investment Bank, Prospectus Department, 299 Park Avenue, New York, NY 10171 or by phone at 212-821-3000.
About ADVENTRX
ADVENTRX Pharmaceuticals is a biopharmaceutical research and development company focused on introducing treatments for cancer and infectious diseases that surpass the performance and safety of existing drugs, by addressing significant problems such as drug metabolism, toxicity, bioavailability and resistance
Whats going on here.. .....news ahead??
ANX left a 10 months descending wedge for finally engaging into a ascending channel.
"ADVENTRX has expanded its product candidate portfolio substantially over the past year and is rapidly advancing its product candidates into the clinic," stated Evan M. Levine, chief executive officer of ADVENTRX. "Depending on preclinical results and anticipated discussions with the FDA, we may have up to five product candidates in clinical development by the end of the year. In the interim, we look forward to announcing results of our 300- patient Phase 2b clinical trial of CoFactor for the treatment of metastatic colorectal cancer and results from our marketing-enabling study of ANX-530 later this year."
Monday May 7 ADVENTRX's announced financial results for the three months ended March 31, 2007
In line with Analyst Estimates:
Q1 2007 pps(fully diluted): (0.06) Versus Q1 2006 pps(fully diluted): (0.06)